Rotatory subluxation of the navicular.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to T Fahey.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
OBJECTIVES: To examine the interaction between general practitioners and pharmaceutical company representatives. DESIGN: Qualitative study of 13 consecutive meetings between general practitioner and pharmaceutical representatives. A dramaturgical model was used to inform analysis of the transcribed verbal interactions. SETTING: Practice in south west England. PARTICIPANTS: 13 pharmaceutical company representatives and one general practitioner. RESULTS: The encounters were acted out in six scenes. Scene 1 was initiated by the pharmaceutical representative, who acknowledged the relative status of the two players. Scene 2 provided the opportunity for the representative to check the general practitioner's knowledge about the product. Scene 3 was used to propose clinical and cost benefits associated with the product. During scene 4, the general practitioner took centre stage and challenged aspects of this information. Scene 5 involved a recovery strategy as the representative fought to regain equilibrium. In the final scene, the representative tried to ensure future contacts. CONCLUSION: Encounters between general practitioners and pharmaceutical representatives follow a consistent format that is implicitly understood by each player. It is naive to suppose that pharmaceutical representatives are passive resources for drug information. General practitioners might benefit from someone who can provide unbiased information about prescribing in a manner that is supportive and sympathetic to the demands of practice. What is already known on this topic Pharmaceutical representatives influence physicians' prescribing in ways that are often unacknowledged by the physicians themselves Meetings with pharmaceutical representatives are associated with increased prescribing costs and less rational prescribing What this study adds Meetings between pharmaceutical representatives and general practitioners follow a consistent format that is implicitly understood by each player General practitioners may cooperate because representatives make them feel valued
How soon can one safely discharge patients admitted to hospital with an exacerbation of asthma? Criteria for discharge were published by the British Thoracic Society in 1990 and revised in 1993. We have reviewed a cohort of patients with asthma discharged over a 12-month period from a busy district general hospital. Most patients were discharged without meeting all the BTS criteria. Outcome measures suggest that this may not matter at least in patients who have received education from a specialist chest liaison nurse and were discharged on oral and inhaled steroids.
Twenty-seven general practitioners associated with the Department of Community Health and General Practice, TCD, agreed to record details of the drugs prescribed on 30 consecutive GMS prescriptions. Doctors were asked to indicate whether the items they were prescribing were initiated by themselves or by a hospital doctor and whether they agreed with the latter items in terms of their clinical appropriateness and cost. Information on 1,471 prescribed items was obtained from a total of 754 prescriptions. General practitioners initiated 63% of these items, hospital doctors 35% and in 2% the person responsible was unknown. Hospital initiated items accounted for 44.5% of total ingredient costs compared with 54% in general practice. General practitioners agreed with most of the hospital initiated items in terms of their clinical appropriateness and cost. Given the extent of hospital initiated GMS prescribing in this study there is a clear need to differentiate between those items originating in hospital and those in general practice for accountability purposes.